Meeting
2019 ASCO Annual Meeting
Performance comparison of the methylated BCAT1/IKZF1 ctDNA test (COLVERA) with the CEA assay for detection of recurrent colorectal cancer.
Authors
Erin L. Symonds
Flinders University, Adelaide, SA, Australia
Erin L. Symonds , Susanne Kartin Pedersen , David Murray , Susan E Byrne , Paul Hollington , Philippa Rabbitt , Frederick S. Jones III, Eva Segelov , Tadd Scott Lazarus , Lawrence Charles Lapointe , Graeme P. Young
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Clinical Trial Registration Number
12611000318987
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3589)
DOI
10.1200/JCO.2019.37.15_suppl.3589
Abstract #
3589
Poster Bd #
81
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
A novel 2-gene blood test for colorectal cancer recurrence.
First Author: Susanne Kartin Pedersen
Poster
2024 ASCO Breakthrough
A novel artificial intelligence-enhanced electrochemical method for rapid methylation detection in cfDNA: Advancing multi-cancer early diagnosis.
First Author: Li-Yue Sun
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A retrospective study of circulating tumor DNA for minimal residual disease detection in the management of colorectal cancer.
First Author: Michael H. Storandt
Poster
2021 ASCO Annual Meeting
Clinical performance of methylation-based liquid biopsy test COLVERA after optimization of test interpretation rules.
First Author: Zivjena Vucetic